FDA
approval
· 2012-10-02
FDA Approved: CYSTARAN — Original Application (Leadiant Biosciences, Inc.)
Summary
The FDA approved CYSTARAN (cysteamine hydrochloride) under its original application from Leadiant Biosciences, Inc. for treating corneal cystine crystal accumul…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for CYSTARAN (CYSTEAMINE HYDROCHLORIDE)